Clinuvel Pharmaceuticals Limited

UR9.F·Frankfurt·Healthcare
Compare
4.6700+0.3690 (+8.58%)today
As of Nov 5, 9:49 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.3010
Open4.6600
Day range4.66004.6700
52-week range4.30107.4500
Off day high0.00%
Off 52-week high−37.32%
Volume500
Avg. volume (3M)208
Market cap235.77M
EPS (TTM)0.3900
Forward P/E—
P/E ratio (TTM)11.97
Dividend yield0.72% (0.0300)
Beta (5Y)0.51
Shares outstanding50.49M
Short interest—
Earnings dateAug 27, 2026
Analyst target—
Profit margin36.07%

Against its peers

Compare in full ›
UR9.F YDES VIVOBIOT.BO FBIO ENTA VRCA
Market cap 235.77M 492.28M 328.87M 65.70M 310.19M 59.35M
P/E (TTM) 12.0 — — 0.7 — —
Forward P/E — — — -1.1 -4.5 -2.8
Price/book 1.4 110.3 0.3 0.4 3.1 13.8
Dividend yield 0.72% — — — — —
1-year change −28.08% −26.14% −57.71% −21.83% −1.39% −3.49%
Today +8.58% +7.84% +6.77% +1.55% +2.70% +5.02%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All UR9.F news ›

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance